title: Model of polymicrobial peritonitis that induces the proinflammatory and immunosuppressive phases of sepsis.
abstract: Severe sepsis is associated with early release of inflammatory mediators that contribute to the morbidity and mortality observed during the first stages of this syndrome. Although sepsis is a deadly, acute disease, high mortality rates have been observed in patients displaying evidence of sepsis-induced immune deactivation. Although the contribution of experimental models to the knowledge of pathophysiological and therapeutic aspects of human sepsis is undeniable, most of the current studies using animal models have focused on the acute, proinflammatory phase. We developed a murine model that reproduces the early acute phases but also the long-term consequences of human sepsis. We induced polymicrobial acute peritonitis (AP) by establishing a surgical connection between the cecum and the peritoneum, allowing the exit of intestinal bacteria. Using this model, we observed an acute phase with high mortality, leukopenia, increased interleukin-6 levels, bacteremia, and neutrophil activation. A peak of leukocytosis on day 9 or 10 revealed the persistence of the infection within the lung and liver, with inflammatory hepatic damage being shown by histological examination. Long-term (20 days) derangements in both innate and adaptive immune responses were found, as demonstrated by impaired systemic tumor necrosis factor alpha production in response to an inflammatory stimulus; a decreased primary humoral immune response and T cell proliferation, associated with an increased number of myeloid suppressor cells (Gr-1(+) CD11b(+)) in the spleen; and a low clearance capacity. This model provides a good approach to attempt novel therapeutic interventions directed to augmenting host immunity during late sepsis.
authors.affiliation: División Inmunología, Instituto de Medicina Experimental, CONICET, Academia Nacional de Medicina de Buenos Aires, Buenos Aires, Argentina.
authors.forename: Gabriela
authors.initials: G
authors.lastname: Barrera
authors.forename: Verónica
authors.initials: V
authors.lastname: Landoni
authors.forename: Daiana
authors.initials: D
authors.lastname: Martire-Greco
authors.forename: Paula
authors.initials: P
authors.lastname: Chiarella
authors.forename: Roberto
authors.initials: R
authors.lastname: Meiss
authors.forename: Sonia A
authors.initials: SA
authors.lastname: Gómez
authors.forename: Fernanda
authors.initials: F
authors.lastname: Alves-Rosa
authors.forename: Barbara
authors.initials: B
authors.lastname: Rearte
authors.forename: Martín
authors.initials: M
authors.lastname: Isturiz
authors.forename: Marina S
authors.initials: MS
authors.lastname: Palermo
authors.forename: Gabriela C
authors.initials: GC
authors.lastname: Fernández
mesh_terms: D000818:Animals; D002432:Cecum / Q000382:microbiology / Q000601:surgery; D016207:Cytokines / Q000276:immunology; D004195:Disease Models, Animal; D007249:Inflammation / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D010537:Peritoneum / Q000601:surgery; D010538:Peritonitis / Q000150:complications* / Q000276:immunology* / Q000382:microbiology; D018805:Sepsis / Q000209:etiology* / Q000276:immunology* / Q000382:microbiology
chemical_list: D016207:Cytokines